This announcement is a separate document:
復星醫藥：根據2022年限制性A股股票激勵計劃向激勵對象首次授予限制性股票結果及更改註冊資本及修訂公司章程
FOSUN PHARMA: RESULTS OF FIRST GRANT OF RESTRICTED SHARES TO PARTICIPANTS UNDER THE 2022 RESTRICTED A SHARE INCENTIVE SCHEME AND CHANGES TO THE REGISTERED CAPITAL AND ARTICLES OF ASSOCIATION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.